• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL1900103 艾托格列净二甲双胍片 ertugliflozin;metformin hydrochloride Tablet Chemical Drugs(5.1) Import Drug Application 2019-05-13 Merck Sharp & Dohme BV In Review 2019-05-11 view
JYHB2200192 艾托格列净片 ertugliflozin Tablet Chemical Drugs Supplementary Application 2022-04-11 view
JYHB2101055 艾托格列净片 ertugliflozin Tablet Chemical Drugs(5.1) Supplementary Application 2021-04-23 view
JXHL1900102 艾托格列净二甲双胍片 ertugliflozin;metformin hydrochloride Tablet Chemical Drugs(5.1) Import Drug Application 2019-05-13 Merck Sharp & Dohme BV In Review 2019-05-11 view
JXHL1900101 艾托格列净二甲双胍片 ertugliflozin;metformin hydrochloride Tablet Chemical Drugs(5.1) Import Drug Application 2019-05-13 Merck Sharp & Dohme Corp In Review 2019-05-11 view
JYHZ2400270 艾托格列净片 ertugliflozin Tablet Chemical Drugs(5.1) License Renew 2024-10-11 view
JXHL1900100 艾托格列净二甲双胍片 ertugliflozin;metformin hydrochloride Tablet Chemical Drugs(5.1) Import Drug Application 2019-05-13 Merck Sharp & Dohme Corp In Review 2019-05-11 view
JYHB2400450 艾托格列净片 ertugliflozin Tablet Chemical Drugs(5.1) Supplementary Application 2024-08-15 view
CXHL1600050 托格列净片 tofogliflozin Tablet Chemical Drugs(3.1) New Drug Application 2016-06-02 南京华威医药科技开发有限公司 Nanjing Huawei Medicine Technology Development Co Ltd Certificate Issued 2017-05-11 view
CXHL1600049 托格列净 tofogliflozin Active ingredient Chemical Drugs(3.1) New Drug Application 2016-06-02 南京华威医药科技开发有限公司 Nanjing Huawei Medicine Technology Development Co Ltd Certificate Issued 2017-05-22 view
JYHB2002203 艾托格列净片 ertugliflozin Tablet Chemical Drugs(5.1) Supplementary Application 2020-11-02 默沙东研发(中国)有限公司 MSD R&D (China) Co Ltd Filed 2020-11-20 view